RBC Life Sciences Inc (RBCL) Financial Statements (2024 and earlier)

Company Profile

Business Address 2301 CROWN COURT
IRVING, TX 75038
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 519 - Miscellaneous Non-durable Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2015
MRQ
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1,9213,7463,896
Cash and cash equivalents 1,9213,7463,896
Receivables 1,286907877
Inventory, net of allowances, customer advances and progress billings 4,7995,1425,085
Inventory 4,7995,1425,085
Prepaid expense  7
Prepaid expense and other current assets833
Deferred tax assets 377430462
Other undisclosed current assets 464786 
Total current assets: 8,84711,01811,154
Noncurrent Assets
Property, plant and equipment 4,6834,1694,488
Intangible assets, net (including goodwill) 2,2612,3012,342
Goodwill 2,2212,2632,298
Intangible assets, net (excluding goodwill) 403844
Other noncurrent assets 20445
Prepaid expense and other noncurrent assets30
Other undisclosed noncurrent assets 00(1)
Total noncurrent assets: 7,1496,5166,860
Other undisclosed assets (0)(0)1
TOTAL ASSETS: 15,99617,53418,014
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 4,2801,2401,181
Interest and dividends payable 7  
Taxes payable 748369
Employee-related liabilities 468  
Accounts payable 2,310  
Accrued liabilities 1,4201,1571,111
Debt 230212197
Deferred revenue and credits 2,1473,6783,231
Other undisclosed current liabilities (549)1,5251,426
Total current liabilities: 6,1076,6556,034
Noncurrent Liabilities
Long-term debt and lease obligation 9071,1361,349
Long-term debt, excluding current maturities 9071,1361,349
Liabilities, other than long-term debt 5567281,117
Deferred tax liabilities, net 5567281,117
Total noncurrent liabilities: 1,4631,8642,465
Total liabilities: 7,5708,5198,499
Equity
Equity, attributable to parent 8,4269,0149,515
Common stock 2222
Additional paid in capital 13,71413,71213,689
Accumulated other comprehensive income 127115119
Accumulated deficit (5,417)(4,814)(4,314)
Total equity: 8,4269,0149,515
TOTAL LIABILITIES AND EQUITY: 15,99617,53418,014

Income Statement (P&L) ($ in thousands)

9/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 28,27025,47125,160
Cost of revenue
(Cost of Goods and Services Sold)
 (12,632)(13,459)(12,528)
Gross profit: 15,63812,01212,632
Operating expenses (16,263)(12,636)(13,096)
Operating loss: (625)(625)(464)
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
 (220)6640
Interest and debt expense (96)(112)(126)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 220(66)(40)
Loss from continuing operations before income taxes: (721)(736)(590)
Income tax benefit 118236228
Loss from continuing operations: (603)(500)(361)
Loss before gain (loss) on sale of properties: (603)(500)(361)
Net loss available to common stockholders, diluted: (603)(500)(361)

Comprehensive Income ($ in thousands)

9/30/2015
TTM
12/31/2014
12/31/2013
12/31/2012
Net loss: (603)(500)(361)
Comprehensive loss: (603)(500)(361)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 12(4)(25)
Comprehensive loss, net of tax, attributable to parent: (591)(504)(386)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: